Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EBITDA (2020 - 2025)

Historic EBITDA for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$21.2 million.

  • PROCEPT BioRobotics' EBITDA fell 111.48% to -$21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.5 million, marking a year-over-year increase of 1553.97%. This contributed to the annual value of -$91.4 million for FY2024, which is 1363.24% up from last year.
  • According to the latest figures from Q3 2025, PROCEPT BioRobotics' EBITDA is -$21.2 million, which was down 111.48% from -$19.9 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' EBITDA ranged from a high of -$12.8 million in Q1 2021 and a low of -$28.5 million during Q1 2023
  • Its 5-year average for EBITDA is -$21.6 million, with a median of -$21.2 million in 2025.
  • Per our database at Business Quant, PROCEPT BioRobotics' EBITDA crashed by 6563.66% in 2023 and then soared by 3169.91% in 2024.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' EBITDA stood at -$18.4 million in 2021, then crashed by 54.65% to -$28.4 million in 2022, then increased by 3.45% to -$27.4 million in 2023, then skyrocketed by 31.7% to -$18.7 million in 2024, then decreased by 13.36% to -$21.2 million in 2025.
  • Its EBITDA stands at -$21.2 million for Q3 2025, versus -$19.9 million for Q2 2025 and -$24.6 million for Q1 2025.